GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, KIT, MET, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
13.9826 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, POLB, PPARA, PTAFR, PTGS2, RORC, SRC, TYR |
12.3141 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ABCG2, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, POLB, PPARA, PTAFR, PTGS2, RORC, SRC, TERT, TOP1, TYR |
11.6473 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, PIK3CA, POLB, PPARA, PTAFR, PTGS2, RORC, SRC, TYR |
11.0734 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
10.7177 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.02925 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, CNR1, CNR2, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
9.02925 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, CNR1, CNR2, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
9.02925 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTAFR, PTGS2, RORC, SRC, TYR |
8.73545 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.24457 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.23624 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TYR |
8.23624 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.1953 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.03713 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, ADORA2A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FUT7, GBA2, HMGCR, PIK3CA, PIM1, PPARA, PTAFR, PTGS1, PTGS2, TBXAS1, TYR, XDH |
7.9377 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ABCG2, ADORA2A, AKR1B1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HMGCR, HSD11B2, KDR, POLB, PTAFR, PTGS2, SRC, TOP1 |
7.84087 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS1, PTGS2, SRC, TERT, XDH |
7.75909 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
7.69442 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.68435 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
7.25243 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
7.20722 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTAFR, PTGS2, RORC, SRC, TYR |
7.187 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
7.16573 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
7.14716 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
6.93284 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTAFR, PTGS2, RORC, SRC, TNKS2, TOP1, TYR |
6.87566 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, ADORA2A, CNR1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.78746 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, KIT, MMP2, PPARA, PTAFR, PTGS2, SRC |
6.58125 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5, PTAFR |
6.58125 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, CDK6, CNR1, HCAR2, HMGCR, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
6.58125 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.58125 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.34069 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.24215 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, RORC, SRC, TERT |
6.10673 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, HMGCR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
6.04141 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
6.01152 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
5.90881 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
5.84552 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, PIK3CA, PTAFR, PTGS2, RORC, SRC |
5.74448 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1 |
5.69043 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, F10, F3, GRIK5, GRM5, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT |
5.61821 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
5.61821 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7, CNR1, CNR2 |
5.61821 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.59734 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, POLA1, POLB, SRC, TERT |
5.59734 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, PPARA, PTAFR, PTGS2, SRC |
5.59488 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
5.49761 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.455 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
5.39384 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.37841 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.3654 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.36134 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TNKS, TNKS2 |
5.36134 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1 |
5.35955 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2, TERT |
5.32087 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PTGS2, RORC, SRC, TERT, TNKS2, TYR |
5.3198 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
5.28512 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.27712 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PTAFR, PTPN1, RORC, SRC, TNKS, TNKS2 |
5.26368 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.26139 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.26139 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, POLA1, POLB, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT |
5.18371 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1 |
5.16854 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, POLB, PTAFR, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
5.13381 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
5.0909 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, KDR, POLB, SRC |
5.04066 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.00501 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.00501 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.94283 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.93845 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.93449 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CDK6, CYP1B1, DNMT1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, RORC, SRC |
4.93449 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
4.91605 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
4.89846 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
4.89693 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APP, CNR1, CNR2, DNMT1, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
4.89562 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, KIT, PIK3CA, POLB, PPARA, SRC, TYR |
4.81205 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.81041 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, POLB, PTAFR, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
4.80242 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.78748 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, AURKB, CA2, CA7, CNR1, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 |
4.74814 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7, GRM5, PTAFR |
4.71275 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, KIT, PPARA, PTGS2, RORC, SRC |
4.69536 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, F10, F3, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.69536 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.67356 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.67082 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, GRM1, HMGCR, HSD11B2, KIT, MMP2, POLB, PPARA, PTAFR, PTGS2, SRC, TERT, TYR |
4.64248 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CDK6, CNR1, CNR2, CYP19A1, DYRK1A, ESR1, F3, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
4.61758 |
[BP] GO:0007187 |
None
|
ADORA1, ADORA2A, CHRM2, CNR1, CNR2, GRM1, GRM3, GRM5, GRM8 |
4.52844 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.51832 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APP, CNR1, CNR2, DNMT1, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
4.50149 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.50027 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.41552 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TNKS, TOP1 |
4.41552 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.39632 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.32397 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
4.3205 |
[BP] GO:0042391 |
None
|
ADORA1, ADORA2A, APP, BCL2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
4.3159 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.3159 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
4.29006 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.28548 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
4.25026 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.24237 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, KIT, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, RORC, SRC, TYR |
4.24237 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.23495 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1 |
4.22055 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.21393 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.15223 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC |
4.12882 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.12882 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH |
4.08905 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1 |
4.07145 |
[BP] GO:0007188 |
None
|
ADORA1, ADORA2A, CHRM2, CNR1, GRM1, GRM3, GRM5, GRM8 |
4.0531 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.03095 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CDK6, CHRM2, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PTAFR, PTGS2, SLC1A1, SRC, TERT, TNKS2, XDH |
4.03095 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.03049 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA2A, ADORA3, AXL, CNR2, KIT, PIK3CA, PIK3CB, POLB, PTAFR, PTGS1, PTGS2 |
3.99777 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, ESR1, KIT, PPARA, RORC, SRC, TOP1 |
3.99335 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP1, XDH |
3.97737 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.96426 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.91347 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, POLB, PPARA, PTGS2, SRC, TERT |
3.91347 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TNKS, TOP1 |
3.86601 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PPARA, PTGS1, PTGS2, TBXAS1 |
3.85171 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.79479 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, APP, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIM1, PTAFR, PTGS2, SLC1A1, SRC, TERT |
3.78538 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB |
3.78538 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.77632 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, GRM1, GRM3, GRM5, GRM8 |
3.76606 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.73745 |
[BP] GO:0060078 |
None
|
ADORA1, ADORA2A, GRIA2, GRIA4, GRIK5, GRM5 |
3.73742 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MET, PIK3CB, PIM1, POLA1, SRC, TYR |
3.68288 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.64241 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.63456 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.60468 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
3.60468 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2, TERT |
3.60394 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.56903 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.56903 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, GRIK5, GRM5, HCAR2, HMGCR, MMP12, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT |
3.56744 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.5631 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.53119 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.53022 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, GRM1, GRM5, KIT, MET, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
3.49084 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, BCL2, CDK6, CNR1, CNR2, CYP19A1, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.47865 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.47748 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADORA2A, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
3.47748 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, XDH |
3.47748 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.47748 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, HMGCR, PTAFR, TYR |
3.46758 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADORA2A, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
3.43617 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.43617 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.4118 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.41012 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.38894 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
3.36894 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.36414 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
3.32678 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESRRA, HCAR2, KIT, MMP12, MMP2, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC |
3.3251 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.31375 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, RORC, SRC |
3.30271 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, HSD11B2, PPARA, PTAFR, PTGS1, PTGS2 |
3.24036 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.23715 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.20661 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.18924 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADORA2A, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
3.15125 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTAFR, PTGS2, SRC |
3.14715 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.13753 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTAFR, PTGS2, SRC |
3.1345 |
[BP] GO:0010359 |
None
|
ABCB1, GRM5, PTAFR |
3.13438 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.13438 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.12867 |
[BP] GO:0099536 |
None
|
ADORA2A, CHRM2, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.04879 |
[BP] GO:0099537 |
None
|
ADORA2A, CHRM2, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.04879 |
[BP] GO:0010942 |
positive regulation of cell death
|
ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
3.02766 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, ADORA2A, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, ESR1, F10, F3, FLT3, FUT7, GBA2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
3.00113 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, KIT, MMP2, MMP9, PTAFR, PTGS2, SRC |
3.00113 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.00113 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HMGCR, POLB, PTGS2, TERT |
2.99321 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
2.97037 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM2, KIT, PTAFR, PTGS2 |
2.96427 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PPARA, PTGS1, PTGS2, TBXAS1 |
2.96193 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, DNMT1, DYRK1A, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.94685 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PTGS2 |
2.93132 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
2.90209 |
[BP] GO:0003008 |
None
|
ADORA1, ADORA2A, AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, GRM1, GRM5, GRM8, HMGCR, HSD11B2, KIT, PIK3CA, PTAFR, PTGS2, SRC, TYR |
2.88871 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
2.88871 |
[BP] GO:0019371 |
None
|
PTGS1, PTGS2, TBXAS1 |
2.88871 |
[BP] GO:0060079 |
None
|
ADORA1, ADORA2A, GRIA2, GRIA4, GRIK5 |
2.85406 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGS2, SRC |
2.83125 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7, PTGS2 |
2.77198 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.77198 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA2A, ADORA3, APP, CA2, CHRM2, CNR1, CNR2, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, PIK3CA, PIK3CB, PTAFR, SRC |
2.77173 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.76649 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
2.76181 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
2.74422 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, CNR1, GRM5, MMP9, PTAFR, PTGS2 |
2.74255 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, FLT3, GRM1, HMGCR, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
2.74034 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.69538 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.68224 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.68224 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, KIT, PIK3CB, PTPN1, SRC |
2.67131 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.64458 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.64458 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.63365 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.62342 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, HCAR2, MMP12, PTAFR, PTGS2, SRC, TERT |
2.59708 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, HSD11B2, IGF1R, PPARA, PTGS2, SRC |
2.59198 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.59145 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.57104 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, KIT, PTAFR, PTGS2 |
2.51027 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.50985 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, PPARA, PTAFR |
2.50814 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.50814 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.5044 |
[BP] GO:0007154 |
None
|
ADORA1, ADORA2A, AXL, BCL2, CHRM2, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1 |
2.50054 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, HSD11B2, KIT, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT |
2.49545 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, HSD11B2, PTAFR, PTGS2 |
2.48342 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.47578 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
ADORA2A, CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.46494 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, SRC, TNKS, TOP1 |
2.45987 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KDR, PTAFR, PTGS2, SRC |
2.45987 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, KDR, SRC |
2.44321 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP1, XDH |
2.44191 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.43845 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.43845 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HMGCR, SRC, TNKS, TNKS2 |
2.41216 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC |
2.37057 |
[BP] GO:0007268 |
None
|
ADORA2A, CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.36783 |
[BP] GO:0098916 |
None
|
ADORA2A, CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.36783 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.36747 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, HMGCR, HSD11B2, KIT, MMP12, PTAFR, PTGS2, SRC, TYR |
2.36747 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.3669 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.36659 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.36659 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.36659 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, ESR1, FABP4, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
2.3614 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.34307 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DNMT1, ESR1, FLT3, GRM5, IGF1R, KIT, MMP2, PTAFR, PTGS2, SRC |
2.32901 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.32332 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
2.31962 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DYRK1A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.31071 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.30963 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, ESR1, FABP4, PPARA, PTGS2 |
2.30256 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.28985 |
[BP] GO:0048167 |
None
|
ADORA1, ADORA2A, APP, GRM5, KIT, PTGS2 |
2.28579 |
[BP] GO:0003018 |
None
|
ADORA1, ADORA2A, HMGCR, PTAFR, PTGS2, SRC |
2.27213 |
[BP] GO:0003014 |
None
|
ADORA1, ADORA2A, AKR1B1, BCL2, HSD11B2 |
2.27213 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CNR1, DNMT1, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.266 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, MMP12, PTAFR, PTGS2, SRC |
2.266 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, GRM5, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.25382 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.25214 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.23122 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, GRM5, KIT, PTPN1, SRC |
2.21336 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.21336 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.21336 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, KIT, PTGS2, SRC |
2.21336 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.21218 |
[BP] GO:0035249 |
None
|
ADORA2A, GRIA2, GRIK5 |
2.19442 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.19123 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, GRM1, PTGS2 |
2.19123 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.19123 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.19123 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
ADORA2A, CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.16944 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
2.16503 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, PIK3CB, SRC |
2.15497 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DYRK1A, SRC, TNKS, TOP1 |
2.15237 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.14126 |
[BP] GO:1903959 |
None
|
ABCB1, GRM5, PTAFR |
2.14126 |
[BP] GO:0001775 |
cell activation
|
ADORA2A, ALOX5, APP, AXL, BCL2, FLT3, FUT7, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, RORC, SRC |
2.12911 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TYR |
2.12911 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.12911 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.12911 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.12911 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.12911 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.12911 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.12911 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.12674 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, MMP12, PTAFR, PTGS2, SRC |
2.1255 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.12032 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
2.11512 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA2A, ADORA3, CHRM2, GRM1, HCAR2, KIT, PTAFR, PTGS2, SLC1A1 |
2.10271 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.10271 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.10271 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.10271 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, ADORA2A, CNR2, CYP19A1, MMP12, PPARA |
2.0947 |
[BP] GO:0007267 |
None
|
ADORA1, ADORA2A, CHRM2, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.08979 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.08979 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.08979 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, KIT, PTPN1, SRC |
2.07171 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
2.061 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.06033 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, XDH |
2.0598 |
[BP] GO:2000117 |
negative regulation of cysteine-type endopeptidase activity
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC |
2.05798 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.05595 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.05595 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, GRM5, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.05563 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.0535 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.04483 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.02841 |
[BP] GO:0051172 |
None
|
ADORA2A, APP, AURKB, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.02322 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADORA2A, APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, PTGS2, RORC, SRC, TERT, TNKS, TNKS2 |
2.00912 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.00717 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
IGF1R, PIK3CA, PIK3CB, PTAFR |
2.00511 |
[CC] GO:0016020 |
membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, F10, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR |
5.61821 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, ESR1, F10, F3, FLT3, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTPN1, SLC1A1, SRC, TERT |
5.40837 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ABCG2, ADORA1, ADORA2A, CA2, CA4, CA9, CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
5.35955 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, F10, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TBXAS1, TYR |
4.8863 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ABCG2, ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, CHRM2, CNR1, CNR2, F10, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PTAFR, PTGS2, SLC1A1, SRC |
4.61758 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CA4, CHRM2, CNR1, CNR2, F10, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
4.60146 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.21497 |
[CC] GO:0043005 |
None
|
ADORA1, ADORA2A, APP, BACE1, CA2, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
4.05241 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, F10, FLT3, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1, TBXAS1 |
3.77632 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, ADORA2A, APP, CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
3.43617 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CHRM2, CNR1, CNR2, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
3.30617 |
[CC] GO:0120025 |
None
|
ADORA1, ADORA2A, AKR1B1, APP, BACE1, CA2, CDK6, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC |
3.18924 |
[CC] GO:0097060 |
None
|
CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.16905 |
[CC] GO:0042995 |
cell projection
|
ADORA1, ADORA2A, AKR1B1, APP, BACE1, CA2, CDK6, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC |
2.89504 |
[CC] GO:0097458 |
None
|
ADORA1, ADORA2A, APP, BACE1, CA2, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS1, PTGS2, SRC, TOP1 |
2.8397 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, TBXAS1 |
2.80555 |
[CC] GO:0014069 |
None
|
ADORA1, ADORA2A, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55784 |
[CC] GO:0099572 |
None
|
ADORA1, ADORA2A, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55784 |
[CC] GO:0044464 |
cell part
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.50814 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.36659 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.36659 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, KIT, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.31071 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.19442 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NQO2, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.00511 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TBXAS1, TNKS, TYR, XDH |
13.4896 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
11.2621 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ABCG2, ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
11.2621 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.28095 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
7.98942 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.60417 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA2A, ADORA3, AXL, CDK6, CHRM2, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
7.30063 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
7.17006 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
6.99006 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD11B2, HSD17B1, NQO2, POLA1, PTGS1, PTGS2, SRC, TBXAS1, XDH |
6.49592 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, TNKS |
6.49592 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
6.1531 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
6.04793 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.9605 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.74391 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.64075 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, SRC, TBXAS1 |
5.5907 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.39189 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, SRC, TBXAS1 |
5.36134 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ABCG2, ACHE, AURKB, AXL, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TOP1 |
5.04086 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PTAFR |
5.04066 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, KIT, MET, PTAFR |
5.04066 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2, TBXAS1, TYR |
5.02189 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TBXAS1, XDH |
4.93449 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.7242 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.7242 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
4.67356 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.60253 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TBXAS1, TYR |
4.33509 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.3159 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.21497 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, POLA1, POLB, SRC, TERT, TOP1 |
4.01337 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ABCG2, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SLC1A1, SRC, TOP1, XDH |
3.98993 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, ADORA2A, AOX1, APP, BCL2, CSNK2A1, DYRK1A, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, MMP9, NQO2, PTGS2, TERT, TYR, XDH |
3.93438 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.78538 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TOP1 |
3.6882 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.67893 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.64241 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
3.60093 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, PTAFR, RORC |
3.5462 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1 |
3.50052 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.45127 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.43133 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.30218 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SRC, TOP1, XDH |
3.23715 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SRC, TOP1, XDH |
3.23657 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.17885 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1 |
3.11589 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ABCG2, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PTAFR, SLC1A1, SRC, TOP1, XDH |
3.09066 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.07132 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.0154 |
[MF] GO:0030594 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.99962 |
[MF] GO:0019899 |
enzyme binding
|
ADORA2A, APP, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, ESR1, ESR2, ESRRB, F3, GRM5, HMGCR, KIT, MET, POLA1, POLB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS2 |
2.98389 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
2.88871 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.76649 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.76649 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.76649 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.44321 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.41149 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.36659 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.36659 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ABCG2, ADORA1, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, XDH |
2.29125 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.25214 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.25214 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.19442 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.12911 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.12911 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.11512 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ABCG2, ADORA1, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, XDH |
2.11415 |